About Roberto Montoya Barraza, MD
Roberto Montoya Barraza, MD, a hematologist and oncologist at Endeavor Health, provides care for people with a wide range of blood disorders and cancers, including solid tumors and hematologic malignancies. He evaluates conditions such as breast, lung, gastrointestinal, gynecologic and genitourinary cancers as well as leukemia and lymphoma. Dr. Montoya Barraza incorporates evidence-based therapies and collaborates closely with patients to develop treatment plans that reflect their goals and priorities. His approach supports patients and families throughout diagnosis, treatment and ongoing care.
Care philosophy
I am committed to providing thoughtful, evidence-based care in oncology and hematology, recognizing that each person’s experience with cancer is unique. I work to understand every patient’s goals and preferences so their treatment plan reflects what matters most to them. I strive to create a supportive environment where patients feel heard and informed as we navigate decisions together. I am grateful for the trust patients place in me and my team as we guide them through their treatment journey.
Overview
- Languages Spanish
- Gender Male
Conditions treated (22)
- Bile duct cancer
- Bladder cancer
- Bone cancer
- Brain and spinal cancer
- Breast cancer
- Cervical cancer
- Colorectal cancer
- Esophageal cancer
- Head and neck cancer
- Kidney cancer
- Leukemia
- Liver cancer
- Lung cancer
- Lymphoma
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Skin cancer
- Stomach cancer
- Testicular and penile cancer
- Thyroid cancer
- Uterine and endometrial cancer
Treatments offered (5)
- Cancer immunotherapy
- Cancer hormonal therapy
- Cancer targeted and biologic therapy
- Chemotherapy
- Cancer genetics counseling
Rolling Meadows, IL 60008-3193
Barrington, IL 60010-1956
-
2005Universidad Peruana Cayetano Heredia
-
2010Internal MedicineUniversity of Connecticut Health Science Center (Farmington)
-
2013Hematology/OncologySUNY Health Science Center-Syracuse (New York)
-
2013HematologyAmerican Board of Internal Medicine
-
2013Medical OncologyAmerican Board of Internal Medicine

